Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

With Abbott India Limited's revenues expected to fall below the previous year's, investors are likely to approach the stock with caution. Declining revenues can negatively affect profitability, which makes it harder for the company to maintain investor confidence and perform well in the market.

Financial Ratios:

currentRatio 2.554000
forwardPE 28.933979
debtToEquity 3.602000
earningsGrowth 0.076000
revenueGrowth 0.065000
grossMargins 0.467050
operatingMargins 0.270120
trailingEps 730.050000
forwardEps 908.793100

Abbott India Limited's current ratio of 2.554 highlights the company's solid liquidity, indicating that it can easily service its short-term debt. Abbott India Limited's ample cash reserves and current assets ensure that the company is well-positioned to meet its immediate financial liabilities.
ABBOTINDIA's Forward PE is positioned well, reflecting a favorable balance between stock price and earnings. The stock isn't overpriced, offering room for growth and making it a potentially rewarding investment as its value has room to rise further.
ABBOTINDIA's positive gross and operating margins indicate the company's ability to operate profitably. These margins reflect strong financial management, with efficient cost control contributing to sustained profitability and a solid financial outlook.
ABBOTINDIA's forward EPS is higher than its trailing EPS, which signals that the company is expected to achieve greater profitability this financial year. This suggests improved earnings performance, indicating a positive outlook for ABBOTINDIA's financial growth.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

Abbott India Limited's current price does not reveal any distinct risks or opportunities compared to its projections. This neutral assessment suggests stability, where investors might choose to retain their current positions until future developments warrant a reassessment.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


The analysts' recent buy bias for ABBOTINDIA indicates strong confidence in the stock's future performance. This could encourage more investors to view ABBOTINDIA as a worthwhile investment, positioning the company as a top choice for those seeking financial security and long-term growth opportunities.